GoHealth Delays Quarterly Report Filing

GoHealth ( (GOCO) ) has released a notification of late filing.

GoHealth, Inc. has filed a Form 12b-25, indicating a delay in submitting its Form 10-Q (Quarter Report) for the period ending March 31, 2025. The delay is due to the need for additional time to review and assess financial data and disclosures, particularly concerning compliance with financial covenants and potential liquidity issues. The company anticipates filing the report within five days of the original deadline. GoHealth has acknowledged potential changes in financial results and expressed substantial doubt about its ability to continue as a going concern without successful implementation of mitigating plans. The company is actively working on compliance efforts, as noted by CFO Brendan Shanahan’s signature on the notification.

The most recent analyst rating on (GOCO) stock is a Hold with a $18.00 price target. To see the full list of analyst forecasts on GoHealth stock, see the GOCO Stock Forecast page.

Spark’s Take on GOCO Stock

According to Spark, TipRanks’ AI Analyst, GOCO is a Neutral.

GoHealth’s overall stock score reflects a balance of strengths and challenges. The company shows robust revenue and EBITDA growth, driven by operational improvements and strategic initiatives. However, ongoing issues with cash flow and profitability, along with a negative P/E ratio, weigh down the stock’s attractiveness. Technical indicators suggest potential bearish momentum, but leadership changes may positively influence future performance.

To see Spark’s full report on GOCO stock, click here.

More about GoHealth

Average Trading Volume: 62,238

Technical Sentiment Signal: Sell

Current Market Cap: $177.8M

For a thorough assessment of GOCO stock, go to TipRanks’ Stock Analysis page.